Earl G. and Gladys C. Davis Distinguished Research Professor in Business
Professor, Marketing Department, W. P. Carey School of Business, 2010-present.
Ph.D., Economics, The Wharton School, University of Pennsylvania, 2002;
B.A., Economics, Baylor University, 1997.
Consumer decision making; physician incentives and learning; prescription drugs and medical devices; health care providers; health insurance markets.
Evaluating the quality of consumer choices; designing incentive programs for physicians; variations in physician spending
Prior Academic Positions Held
Assistant Professor, School of Health Management and Policy, W. P. Carey School of Business, 2005-2010;
Visiting Scholar, Robert Wood Johnson Foundation Scholars in Health Policy Research Program, University of California, Berkeley and UCSF.
Honors and Awards
NIHCM Foundation's Nineteenth Annual Health Care Research Award winner, 2013.
ASU Faculty Achievement Award, Defining Edge Research and Creative Work, Best Professional Application, 2013.
John D. Thompson Prize for Young Investigators. Awarded by the Association of University Programs in Health Administration, 2010.
Jonathan Ketcham, Nicolai Kuminoff, and Christopher Powers. “Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Comment.” Forthcoming, American Economic Review.
Jonathan Ketcham, Claudio Lucarelli, and Christopher Powers. 2015. “Paying Attention or Paying Too Much in Medicare Part D.” American Economic Review, 105(1): 204-233.
Andrew Epstein and Jonathan Ketcham. 2014. “Information Technology and Agency in Physicians’ Prescribing Decisions.” RAND Journal of Economics, 45(2): 422-448.
James Niels Rosenquist, Jonathan Ketcham, Haizhen Lin and Kosali Simon. 2013. “The Impact of the 2006-2009 United States Housing Crisis on Antidepressant Medication Utilization.” Economics Letters, 121: 449-453.
Jonathan Ketcham, Claudio Lucarelli, Eugenio Miravete and M. Christopher Roebuck. 2012. “Sinking, Swimming, or Learning to Swim in Medicare Part D.” American Economic Review, 102(6): 2639-2673.
Andrew Epstein, Jonathan Ketcham, Saif Rathore and Peter Groeneveld. 2012. “Variations in Access to Innovation by Payer: The Case of Drug-Eluting Stents.” Medical Care, 50(1): 1-9.
Andrew Epstein, Jonathan Ketcham, and Sean Nicholson. 2010. “Specialization and Matching in Professional Firms.” RAND Journal of Economics, 41(4): 812–835.
Saif Rathore, Jonathan Ketcham, G. Caleb Alexander, and Andrew Epstein. 2009. “Influence of Patient Race on Physician Prescribing Decisions: A Randomized On-line Experiment.” Journal of General Internal Medicine, 24(11): 1183-91.
Jonathan Ketcham, Karen Lutfey, Eric Gerstenberger, Carol Link and John McKinlay. 2009. “Physician Clinical Information Technology and Health Care Disparities.” Medical Care Research and Review, 66(6): 658-681.
Jonathan Ketcham and Kosali Simon. 2008. “Medicare Part D's Effects on Elderly Drug Costs and Utilization.” American Journal of Managed Care, 14(11): SP14-22. Previously NBER working paper #14326.
Jonathan Ketcham and Jeffrey Ngai. 2008. “How Similar are States’ Medicaid Preferred Drug Lists?” American Journal of Managed Care, 14(11): SP46-52.
Andrew Epstein, Saif Rathore, G. Caleb Alexander, and Jonathan Ketcham. 2008. “Primary Care Physicians’ Views on Medicare Part D.” American Journal of Managed Care, 14(11): SP5-13.
Jonathan Ketcham and Michael Furukawa. 2008. “Hospital-Physician Gainsharing in Cardiology.” Health Affairs 27(3): 803-812.
Glenn Melnick and Jonathan Ketcham. 2008. “Have HMOs Broadened their Hospital Networks: Changes in HMO Hospital Networks in California, 1999-2003.” Medical Care 46(3): 339-342.
Jonathan Ketcham and Andrew Epstein. 2008. “Medicaid Preferred Drug Lists’ Costs to Physicians.” Medical Care 46(1): 9-16.
Michael Furukawa, Jonathan Ketcham and Mary Rimsza. 2007. “Physician Practice Revenues and Use of Information Technology in Patient Care.” Medical Care. 45(2): 168-176.
Jonathan Ketcham, Laurence Baker, and Donna MacIsaac. 2007. “Physician practice size and variations in treatments and outcomes: Evidence from Medicare patients with acute myocardial infarction.” Health Affairs. 26(1): 195-205.
Jonathan Ketcham and Andrew Epstein. 2006. “Which Physicians are Affected Most by Medicaid Preferred Drug Lists for Statins and Antihypertensives?” PharmacoEconomics. 24(S3): 27-40.
Karen Lutfey and Jonathan Ketcham. 2005. “Patient and provider assessments of adherence and the source of disparities: Evidence from diabetes care.” Health Services Research. 40(6): 1803-1817.
Kevin Volpp, Jonathan Ketcham, Andrew Epstein, and Sankey Williams. 2005. “The effects of price competition and reduced subsidies for uncompensated care on hospital mortality.” Health Services Research. 40(4): 1056-1077.
Daniel Eisenberg and Jonathan Ketcham. 2004. “Economic voting in US presidential elections: Who blames whom for what.” The Berkeley Electronic Journal of Economic Analysis & Policy. 4(1): Article 19.
Patricia Danzon and Jonathan Ketcham. 2004. “Reference pricing of pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand.” Forum for Health Economics and Policy (The Berkeley Electronic Press). 7(1): Article 2. Previously NBER working paper #10007.
ASU is a tier 1 research university and W. P. Carey is proud of its strong tradition of teaching and classroom excellence. Our students directly benefit from the research and theories our faculty brings into the classroom. Below is a list of courses being taught during the current semester by this faculty member. Click a course to view it in the ASU course catalog.
MKT 352 - Marketing Research
Knowledge and skills to make intelligent decisions in the design, evaluation and application of marketing research and market data.